In fact, treatment of colonic IECs with TNF-α, IFNγ or butyrate regulate the synthesis of NOD2 at the mRNA level, likely indicating that inflammation during IBD drives the increase in NOD2 signaling [224,225,226]. The gene discussed is NOD2; the disease is inflammatory bowel disease.